Clinical Trials in New York

Showing 7301-7320 of 22,668 trials

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

NCT02702492

This study will evaluate the safety, tolerability, and efficacy of oral KPT-9274 for the treatment of patients with advanced solid malignancies or non-Hodgkin's lymphoma (NHL).

Solid TumorsNHL

Karyopharm Therapeutics Inc60 participantsStarted Jun 2016

Los Angeles, California, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +5 more locations

RECRUITINGPhase 1/2< 1 mile

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

NCT05824975

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional anti-cancer drugs, pembrolizumab or trastuzumab deruxtecan(T-DXd) over a range of advanced and/or metastatic solid tumors.

Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more

GI Innovation, Inc.358 participantsStarted May 2023

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +8 more locations

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Find Trials by Condition in New York

Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)

Pilot Study to Evaluate the CereVasc® EShunt® System in the Treatment of Communicating Hydrocephalus

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

A Multi Center Study of Sexual Toxicities After Radiotherapy

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

First in Human Study of M1069 in Advanced Solid Tumors

Student Exercise and Sleep Timing Study - Part 2

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Real-World Evidence (RWE) Data Analysis of 1-year Consecutive Use of Remote Electrical Neuromodulation (REN)

Observational Study to Assess Migraine Prediction Tool

FPA150 in Patients With Advanced Solid Tumors

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Glyburide Advantage in Malignant Edema and Stroke Pilot

Real-World Evaluation of Eko Algorithms in a Point of Care Setting

Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia